Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disease markers in acute multiple sclerosis

P C Dowling, S D Cook

    Archives of Neurology
    |October 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Acute phase reactants like C-reactive protein and serum IgM levels are elevated in multiple sclerosis (MS) patients with active disease. Monitoring these markers may help assess disease progression in MS.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Successful conservative management of urinary tract rupture in dogs and cats: 52 cases (2003-2024).

    The Journal of small animal practice·2025
    Same author

    Multimodality diagnostic imaging findings in a dog with a traumatic pulmonary pseudocyst.

    The Journal of small animal practice·2020
    Same author

    Joint Laxity and Proprioception in the Knee.

    The Physician and sportsmedicine·2016
    Same author

    The effect of abductor forces on femoral stem stresses in cemented prosthetic hip replacement.

    Orthopedics·2014
    Same author

    Early, design-related failure in total knee arthroplasty a case report.

    Orthopedics·2014
    Same author

    Pyrolite carbon implants in the metacarpophalangeal joint of baboons.

    Orthopedics·2014
    Same journal

    Incorrect Table Entries and Word.

    Archives of neurology·2016
    Same journal

    IDEAL for CCSVI Research-Reply.

    Archives of neurology·2013
    Same journal

    Atlas of Inherited Metabolic Diseases, 3rd ed.

    Archives of neurology·2013
    Same journal

    Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

    Archives of neurology·2013
    Same journal

    This month in archives of neurology.

    Archives of neurology·2013
    Same journal

    About this journal.

    Archives of neurology·2013
    See all related articles

    Area of Science:

    • Neurology
    • Immunology
    • Biochemistry

    Background:

    • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
    • Acute phase reactants (APRs) are proteins whose plasma concentrations increase or decrease in response to inflammation.
    • Elevated APRs are associated with inflammation and tissue destruction.

    Purpose of the Study:

    • To investigate the levels of specific acute phase reactants and serum IgM in patients with multiple sclerosis during acute exacerbations.
    • To determine if these serum components correlate with disease activity in MS.

    Main Methods:

    • Serum levels of C-reactive protein, C3 proactivator, orosomucoid (all acute phase reactants), and immunoglobulin M (IgM) were measured.
    • Measurements were taken in patients hospitalized with acute exacerbations of multiple sclerosis.

    Related Experiment Videos

  • Serial studies were conducted in two patients to observe changes over time.

    • Main Results:

    • Significantly elevated levels of one or more measured serum components were detected in 12 out of 13 patients with clinically active MS.
    • In two patients studied serially, clinical improvement correlated with a decrease in the levels of these serum factors.
    • These findings indicate a potential link between acute phase reactants, IgM, and MS disease activity.

    Conclusions:

    • Measurement of C-reactive protein, C3 proactivator, orosomucoid, and serum IgM may serve as valuable biomarkers.
    • These biomarkers could aid in assessing the progression and activity of multiple sclerosis.
    • Further research is warranted to validate these findings and explore their clinical utility in MS management.